Author: Keith Ashcroft - Page 2
Immunosuppressive Combinations: Generic Options for Transplant Care
- Keith Ashcroft
- |
- |
- 13
Generic immunosuppressants like tacrolimus and mycophenolate offer the same protection as brand-name drugs at 80% lower cost. Learn how they work, their risks, and why they’re now the standard for transplant care.
View moreHow to Use Pharmacy Apps to Track Potential Drug Interactions
- Keith Ashcroft
- |
- |
- 12
Learn how to use pharmacy apps to spot dangerous drug interactions before they happen. Discover the best apps for patients and pros, how they work, and how to avoid costly mistakes with prescriptions, supplements, and OTC meds.
View moreMuscle Aches from Statins: What Really Causes It and What to Do
- Keith Ashcroft
- |
- |
- 15
Muscle aches from statins are common but often overestimated. Learn what's really causing the pain, when to worry, and how to stay protected without quitting your heart medication.
View moreAnnual Boxed Warnings Summary: What Changed and Why It Matters
- Keith Ashcroft
- |
- |
- 0
The 2025 FDA boxed warnings update reveals new, specific safety alerts for drugs like GLP-1 agonists and immunomodulators. These changes mean clearer guidance for doctors and safer use for patients.
View moreMonitoring During Immunosuppressive Therapy: Essential Lab Tests and Imaging for Safety and Effectiveness
- Keith Ashcroft
- |
- |
- 13
Essential lab tests and imaging for patients on immunosuppressive therapy to prevent rejection, toxicity, and infection. Learn how drug levels, TTV monitoring, and routine blood work keep you safe long-term.
View morePTSD Nightmares: How Prazosin and Sleep Therapies Actually Work
- Keith Ashcroft
- |
- |
- 14
PTSD nightmares are more than bad dreams-they're a neurological symptom that disrupts recovery. Learn how prazosin, CBT-I, and imagery rehearsal therapy work, what the research says, and which approach is right for you.
View moreFDA Listing for Biosimilars: How They Are Evaluated and Approved
- Keith Ashcroft
- |
- |
- 8
The FDA doesn't rate biosimilars like generics - it rigorously evaluates them for molecular similarity, safety, and efficacy. Learn how the approval process works, why only 17 are interchangeable, and how they're changing patient access to biologics.
View moreWhen to Recommend Authorized Generics: Pharmacist’s Practical Guide
- Keith Ashcroft
- |
- |
- 9
Pharmacists should recommend authorized generics for patients with allergies, narrow therapeutic index drugs, or modified-release formulations. Learn when and why to suggest them over regular generics.
View morePrinting Medication Guides at Pharmacies: Know Your Rights and How to Request Them
- Keith Ashcroft
- |
- |
- 12
You have the legal right to receive a printed Medication Guide when picking up certain prescription drugs. Learn what these guides are, why they matter, and how to request one-even if the pharmacy says no.
View moreCombination NTI Drugs and Generic Availability: Coverage and Gaps
- Keith Ashcroft
- |
- |
- 12
Combination NTI drugs offer powerful treatment for complex conditions, but generic versions are nearly nonexistent due to strict bioequivalence requirements and high safety risks. Patients face gaps in access and monitoring, with real-world consequences.
View more